Literature DB >> 24290727

The emergence of community-onset Clostridium difficile infection in a tertiary hospital in Singapore: a cause for concern.

X Q Tan1, A J Verrall1, R Jureen2, T V Riley3, D A Collins3, R T Lin2, M N Balm2, D Chan2, P A Tambyah4.   

Abstract

Increasing rates of Clostridium difficile infection (CDI) among those without traditional risk factors have been reported mainly in Europe and North America. Here we describe the epidemiology, clinical features and ribotypes of CDI at National University Hospital (NUH), a 1000-bed tertiary care hospital in Singapore, from December 2011 to May 2012. All laboratory-confirmed CDI cases ≥21 years old who gave informed consent were included. Clinical data were collected prospectively and participants underwent an interviewer-administered questionnaire. Cases were classified by healthcare facility exposure and severity according to the SHEA guidelines. Included cases were also subjected to PCR and were classified by ribotype. In total, 66 patients participated in the study, of which 33 (50.0%) were healthcare-facility-associated hospital onset (HCFA-HO). Of the 33 community-onset (CO) cases, 14 (42.4%) were HCFA-CO, 10 (30.3%) were indeterminate and 9 (27.3%) were community-associated (CA). Of the CA cases, a majority (90.9%) had prior exposure to a healthcare facility within the last 12 weeks. Clinical characteristics, exposures and outcomes were not different between HO-CDI and CO-CDI. Diagnosis was delayed in CO-CDI compared with HO-CDI (4 days vs. 1 day; P=0.014). There was no difference in distribution of ribotypes between CO-CDI and HO-CDI, with 053 being most prevalent in both groups. CO-CDI increasingly contributes to the burden of CDI in NUH. This may reflect a trend in other parts of Asia. Healthcare professionals should be aware of the possible role of outpatient healthcare environments to CDI risk and thus extend control measures to outpatient settings.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Infection control; Ribotyping

Mesh:

Year:  2013        PMID: 24290727     DOI: 10.1016/j.ijantimicag.2013.09.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

Authors:  Thomas V Riley; Deirdre A Collins; Rina Karunakaran; Maria Abdul Kahar; Ariza Adnan; Siti Asma Hassan; Nadiah Hanim Zainul; F R Mohammed Rustam; Z Abd Wahab; Ramliza Ramli; Yeong Yeh Lee; Hamimah Hassan
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

2.  Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.

Authors:  Peng An Khun; Thomas V Riley
Journal:  Am J Trop Med Hyg       Date:  2022-08-08       Impact factor: 3.707

3.  Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.

Authors:  Nicole Stoesser; David W Eyre; T Phuong Quan; Heather Godwin; Gemma Pill; Emily Mbuvi; Alison Vaughan; David Griffiths; Jessica Martin; Warren Fawley; Kate E Dingle; Sarah Oakley; Kazimierz Wanelik; John M Finney; Melina Kachrimanidou; Catrin E Moore; Sherwood Gorbach; Thomas V Riley; Derrick W Crook; Tim E A Peto; Mark H Wilcox; A Sarah Walker
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

4.  A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions.

Authors:  Natasha Nanwa; Beate Sander; Murray Krahn; Nick Daneman; Hong Lu; Peter C Austin; Anand Govindarajan; Laura C Rosella; Suzanne M Cadarette; Jeffrey C Kwong
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

5.  Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand.

Authors:  P Putsathit; M Maneerattanaporn; P Piewngam; P Kiratisin; T V Riley
Journal:  New Microbes New Infect       Date:  2016-10-21

6.  Clostridioides difficile infection in the Asia-Pacific region.

Authors:  Deirdre A Collins; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Briony Elliott; Thomas V Riley; Kazuhiro Tateda
Journal:  Emerg Microbes Infect       Date:  2019-12-24       Impact factor: 7.163

7.  Community-Onset Clostridioides Difficile Infection in Hospitalized Patients in The Netherlands.

Authors:  M J T Crobach; D W Notermans; C Harmanus; I M J G Sanders; S C De Greeff; E J Kuijper
Journal:  Open Forum Infect Dis       Date:  2019-11-26       Impact factor: 3.835

8.  Clostridium difficile infection in a French university hospital: Eight years of prospective surveillance study.

Authors:  Nagham Khanafer; Luc Oltra; Monique Hulin; Olivier Dauwalder; Francois Vandenesch; Philippe Vanhems
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 9.  Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.

Authors:  Lauren E Bloomfield; Thomas V Riley
Journal:  Infect Dis Ther       Date:  2016-07-01

10.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.